240 related articles for article (PubMed ID: 12845630)
1. Expression of VEGF, semaphorin SEMA3F, and their common receptors neuropilins NP1 and NP2 in preinvasive bronchial lesions, lung tumours, and cell lines.
Lantuéjoul S; Constantin B; Drabkin H; Brambilla C; Roche J; Brambilla E
J Pathol; 2003 Jul; 200(3):336-47. PubMed ID: 12845630
[TBL] [Abstract][Full Text] [Related]
2. Expression of semaphorins, vascular endothelial growth factor, and their common receptor neuropilins and alleic loss of semaphorin locus in epithelial ovarian neoplasms: increased ratio of vascular endothelial growth factor to semaphorin is a poor prognostic factor in ovarian carcinomas.
Osada R; Horiuchi A; Kikuchi N; Ohira S; Ota M; Katsuyama Y; Konishi I
Hum Pathol; 2006 Nov; 37(11):1414-25. PubMed ID: 17010410
[TBL] [Abstract][Full Text] [Related]
3. Neuropilin 1 and neuropilin 2 co-expression is significantly correlated with increased vascularity and poor prognosis in nonsmall cell lung carcinoma.
Kawakami T; Tokunaga T; Hatanaka H; Kijima H; Yamazaki H; Abe Y; Osamura Y; Inoue H; Ueyama Y; Nakamura M
Cancer; 2002 Nov; 95(10):2196-201. PubMed ID: 12412174
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of vascular endothelial growth factor and its receptors in bronchial dypslasia demonstrated by quantitative RT-PCR analysis.
Merrick DT; Haney J; Petrunich S; Sugita M; Miller YE; Keith RL; Kennedy TC; Franklin WA
Lung Cancer; 2005 Apr; 48(1):31-45. PubMed ID: 15777969
[TBL] [Abstract][Full Text] [Related]
5. Segregation of arterial and venous markers in subpopulations of blood islands before vessel formation.
Herzog Y; Guttmann-Raviv N; Neufeld G
Dev Dyn; 2005 Apr; 232(4):1047-55. PubMed ID: 15739224
[TBL] [Abstract][Full Text] [Related]
6. Semaphorin SEMA3F has a repulsing activity on breast cancer cells and inhibits E-cadherin-mediated cell adhesion.
Nasarre P; Kusy S; Constantin B; Castellani V; Drabkin HA; Bagnard D; Roche J
Neoplasia; 2005 Feb; 7(2):180-9. PubMed ID: 15802023
[TBL] [Abstract][Full Text] [Related]
7. The angiogenic peptide vascular endothelial growth factor (VEGF) is expressed in chronic sacral pressure ulcers.
Pufe T; Paulsen F; Petersen W; Mentlein R; Tsokos M
J Pathol; 2003 May; 200(1):130-6. PubMed ID: 12692851
[TBL] [Abstract][Full Text] [Related]
8. Autocrine VEGF-A system in podocytes regulates podocin and its interaction with CD2AP.
Guan F; Villegas G; Teichman J; Mundel P; Tufro A
Am J Physiol Renal Physiol; 2006 Aug; 291(2):F422-8. PubMed ID: 16597608
[TBL] [Abstract][Full Text] [Related]
9. Semaphorin SEMA3F localization in malignant human lung and cell lines: A suggested role in cell adhesion and cell migration.
Brambilla E; Constantin B; Drabkin H; Roche J
Am J Pathol; 2000 Mar; 156(3):939-50. PubMed ID: 10702410
[TBL] [Abstract][Full Text] [Related]
10. Competing autocrine pathways involving alternative neuropilin-1 ligands regulate chemotaxis of carcinoma cells.
Bachelder RE; Lipscomb EA; Lin X; Wendt MA; Chadborn NH; Eickholt BJ; Mercurio AM
Cancer Res; 2003 Sep; 63(17):5230-3. PubMed ID: 14500350
[TBL] [Abstract][Full Text] [Related]
11. Semaphorin SEMA3F affects multiple signaling pathways in lung cancer cells.
Potiron VA; Sharma G; Nasarre P; Clarhaut JA; Augustin HG; Gemmill RM; Roche J; Drabkin HA
Cancer Res; 2007 Sep; 67(18):8708-15. PubMed ID: 17875711
[TBL] [Abstract][Full Text] [Related]
12. Angiogenesis, vascular endothelial growth factor and its receptors in human surgical wounds.
Kumar I; Staton CA; Cross SS; Reed MW; Brown NJ
Br J Surg; 2009 Dec; 96(12):1484-91. PubMed ID: 19918856
[TBL] [Abstract][Full Text] [Related]
13. Gene expression of neuropilin-1 and its receptors, VEGF/Semaphorin 3a, in normal and cancer cells.
Haixia D; Jingsong Z; Lei J; Hairong D; Jun W; Hang X; Weixian C
Cell Biochem Biophys; 2011 Jan; 59(1):39-47. PubMed ID: 20711684
[TBL] [Abstract][Full Text] [Related]
14. Neuropilins in physiological and pathological angiogenesis.
Staton CA; Kumar I; Reed MW; Brown NJ
J Pathol; 2007 Jul; 212(3):237-48. PubMed ID: 17503412
[TBL] [Abstract][Full Text] [Related]
15. Expression of neuropilin-1 by human glomerular epithelial cells in vitro and in vivo.
Harper SJ; Xing CY; Whittle C; Parry R; Gillatt D; Peat D; Mathieson PW
Clin Sci (Lond); 2001 Oct; 101(4):439-46. PubMed ID: 11566082
[TBL] [Abstract][Full Text] [Related]
16. Neuropilin-1 and neuropilin-2 enhance VEGF121 stimulated signal transduction by the VEGFR-2 receptor.
Shraga-Heled N; Kessler O; Prahst C; Kroll J; Augustin H; Neufeld G
FASEB J; 2007 Mar; 21(3):915-26. PubMed ID: 17185751
[TBL] [Abstract][Full Text] [Related]
17. Expression of class 3 semaphorins and their receptors in human breast neoplasia.
Staton CA; Shaw LA; Valluru M; Hoh L; Koay I; Cross SS; Reed MW; Brown NJ
Histopathology; 2011 Aug; 59(2):274-82. PubMed ID: 21884206
[TBL] [Abstract][Full Text] [Related]
18. Possible role of semaphorin 3F, a candidate tumor suppressor gene at 3p21.3, in p53-regulated tumor angiogenesis suppression.
Futamura M; Kamino H; Miyamoto Y; Kitamura N; Nakamura Y; Ohnishi S; Masuda Y; Arakawa H
Cancer Res; 2007 Feb; 67(4):1451-60. PubMed ID: 17308083
[TBL] [Abstract][Full Text] [Related]
19. Regulation of the pro-angiogenic microenvironment by carboxyamido-triazole.
Oliver VK; Patton AM; Desai S; Lorang D; Libutti SK; Kohn EC
J Cell Physiol; 2003 Oct; 197(1):139-48. PubMed ID: 12942550
[TBL] [Abstract][Full Text] [Related]
20. Semaphorin SEMA3F and VEGF have opposing effects on cell attachment and spreading.
Nasarre P; Constantin B; Rouhaud L; Harnois T; Raymond G; Drabkin HA; Bourmeyster N; Roche J
Neoplasia; 2003; 5(1):83-92. PubMed ID: 12659673
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
